Seizure Rescue Medication: Caregiver Education in a Simulation Setting

NCT ID: NCT03562351

Last Updated: 2020-09-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

17 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-01

Study Completion Date

2019-09-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

1\. Design an educational quality improvement program to assess the most effective educational approach on caregiver seizure RM application. The investigators hypothesize that this educational program will improve caregiver comfort, knowledge of emergent seizure care, and time to medication application.

Specifically, the aims include:

1. Create an educational video reviewing RM administration
2. Develop and validate a simulation training model/mannequin for rectal diazepam administration
3. Expand training to other seizure RMs (e.g. intranasal midazolam, buccal lorazepam) and transition the most effective educational model back to the clinics/bedside to standardize caregiver teaching throughout the department/hospital

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators will implement an intervention jointly with a simulation program to determine the most effective training model: verbal instructions, instructional video, or use of a mannequin. Caregivers will undergo a training curriculum, and 60 caregivers (20 assigned to each educational model) will be matched into three groups and assigned to participate in one of three educational models in the SIM Center. Pre-and post-training questionnaires will be distributed to assess provider knowledge and comfort level. Scoring of caregiver technique administering rectal diazepam to a mannequin and time to RM administration will be obtained to compare between the three educational arms of the study. Thirty additional patients (10 per group) will not receive an assessment of caregiver technique administering RM to the mannequin prior to the educational intervention to control for exposure to the mannequin. Ultimately, the most effective educational method in this simulation pilot study will be expanded to other RM types (e.g. intranasal midazolam, buccal lorazepam), standardized, and brought back to the clinics/bedside throughout the hospital.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Status Epilepticus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The investigators will implement an intervention jointly with our simulation program to determine the most effective training model: verbal instructions, instructional video, or use of a mannequin. Caregivers will undergo a training curriculum, and 90 caregivers (30 assigned to each educational model) will be matched into three groups and assigned to participate in one of three educational models in the SIM Center.
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Verbal Instructions on use of RM

Caregivers will undergo an educational intervention with typical training with verbal instructions and use of a rectal diazepam trainer.

Group Type EXPERIMENTAL

Verbal Instructions Educational Intervention

Intervention Type OTHER

Caregivers will undergo training with verbal instructions

Video on use of RM

Caregivers will undergo an educational intervention with training by watching an instructional video regarding rescue medication administration

Group Type EXPERIMENTAL

Video Educational Intervention

Intervention Type OTHER

Caregivers will undergo training with an educational video

Mannequin on use of RM

Caregivers will undergo an educational intervention with training by use of a mannequin to practice administering the rescue medication

Group Type EXPERIMENTAL

Mannequin Educational Intervention

Intervention Type OTHER

Caregivers will undergo training with a mannequin

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Verbal Instructions Educational Intervention

Caregivers will undergo training with verbal instructions

Intervention Type OTHER

Video Educational Intervention

Caregivers will undergo training with an educational video

Intervention Type OTHER

Mannequin Educational Intervention

Caregivers will undergo training with a mannequin

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adult caregivers of patients with epilepsy followed at BCH with the following:

1. At least one seizure \>5 minutes
2. Prescription for rectal diazepam rescue medication
3. Admission for seizure/neurologic problem or neurology/epilepsy clinic visit during the enrollment period
2. Adult caregivers of patients without epilepsy

Exclusion Criteria

1. Adult caregivers of epilepsy patients without a rectal diazepam prescription
2. Non-English-speaking caregivers
Minimum Eligible Age

2 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boston Children's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tobias Loddenkemper

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Boston Children's Hospital

Boston, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P00027241

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ESIS in Pediatric DRE
NCT05469373 RECRUITING